Skip to main content
Premium Trial:

Request an Annual Quote

Mount Sinai Selects Avere's Networked-Attached Storage Appliance for Genome Sequencing Data


Avere Systems said this week that the Genomics Institute at Mount Sinai School of Medicine has implemented the firm's FXT Series network-attached storage appliance in a bid to reduce the time needed to process genome sequencing jobs.

Specifically, Mount Sinai implemented the FXT 2300, which is comprised of eight 146 GB 15K SAS drives and supports an application working set of 1.2 TB per appliance and up to 29 TB per cluster.

In a statement, Ravi Sachidanandam, an assistant professor of genetics and genomic sciences at Mount Sinai, explained that the center's SNP analysis "parallelized pipeline" is used to align hundreds of millions of fragments of RNA/DNA against the human genome and "is very disk-intensive with lots of reads and writes."

He said that Avere's system has helped "minimize these read/write bottlenecks" and reduced the amount of time needed to process jobs from 12 hours to less than six hours.

Avere's FXT Series contains both solid state storage and traditional hard drives and allocates reads, writes, and metadata to storage media using a tiered approach. The platform uses allocation algorithms running on the FXT appliances monitor to access frequency patterns and workload type and manage data placement on multiple internal tiers.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.